Bayer AG
XETRA:BAYN
Bayer AG
Accounts Payable
Bayer AG
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Accounts Payable
€7.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Accounts Payable
$4.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Accounts Payable
€2.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
MPH Health Care AG
XETRA:93M1
|
Accounts Payable
€50.9k
|
CAGR 3-Years
28%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Accounts Payable
€86.6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Accounts Payable
€8.8m
|
CAGR 3-Years
121%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Accounts Payable?
Accounts Payable
7.5B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Accounts Payable amounts to 7.5B EUR.
What is Bayer AG's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
5%
Over the last year, the Accounts Payable growth was -1%. The average annual Accounts Payable growth rates for Bayer AG have been 10% over the past three years , 4% over the past five years , and 5% over the past ten years .